ADENOSINE DEAMINASE, ADA - SERUM

Adenosine Deaminase (ADA) – Serum is a blood test that measures the activity of the adenosine deaminase enzyme in serum. ADA plays an important role in purine metabolism and the normal development and functioning of the immune system, particularly lymphocytes. Increased serum ADA activity may occur when the immune system is activated by certain infections or inflammatory conditions.

This test may be requested as a supportive investigation when tuberculosis or another condition associated with increased cellular immune activity is suspected. Serum ADA results are not specific enough to diagnose tuberculosis independently. Doctors interpret the result together with symptoms, clinical examination, imaging, microbiological tests, molecular tests, culture results, and other relevant investigations.

Benefits of the Test

• Measures adenosine deaminase activity in serum.
• Provides supportive information during tuberculosis evaluation.
• May help assess cellular immune-system activity.
• Supports the investigation of selected infectious conditions.
• May contribute to the evaluation of inflammatory disorders.
• Requires only a routine blood sample.
• Can be performed along with other tuberculosis investigations.
• Provides quantitative laboratory information for clinical correlation.
• May support follow-up assessment when specifically recommended.
• Helps doctors plan further investigations based on the complete clinical picture.

Why Doctors Recommend This Test

Doctors may recommend the Serum ADA test when a patient has symptoms or clinical findings that raise suspicion of tuberculosis, such as prolonged fever, persistent cough, unexplained weight loss, night sweats, fatigue, or reduced appetite. It may also be requested in selected cases involving inflammatory, immune-related, liver, or haematological conditions. Serum ADA is generally used as a supportive biochemical marker and should not replace confirmatory tuberculosis tests.

Preparation Before Test

• No fasting is generally required unless instructed otherwise.
• A blood sample is collected from a vein and serum is used for testing.
• Inform your doctor about all medicines, vitamins, and supplements you take.
• Do not stop any prescribed medicine without medical advice.
• Inform your doctor if you are receiving anti-tuberculosis treatment.
• Share any history of tuberculosis or recent exposure to a person with tuberculosis.
• Inform the doctor about liver disease, autoimmune disorders, or blood-related conditions.
• Carry previous chest imaging, sputum, molecular, culture, or ADA reports if available.
• Follow the sample-collection instructions given by the laboratory.
• Maintain normal hydration unless your doctor has advised fluid restriction.

Normal Reporting Time

The Adenosine Deaminase, ADA – Serum test is generally reported within a few working days after sample collection, processing, analysis, validation, and quality review. The exact reporting time may vary according to the testing schedule, analytical method, sample condition, and laboratory workflow.

Who Should Take This Test?

This test may be recommended for:

• Patients being evaluated for suspected tuberculosis.
• Individuals with persistent fever, cough, night sweats, or unexplained weight loss.
• Patients with clinical or imaging findings suggestive of tuberculosis.
• Individuals with a history of close contact with a tuberculosis patient.
• Patients requiring additional supportive testing after inconclusive initial investigations.
• Individuals undergoing evaluation for selected inflammatory conditions.
• Patients with certain immune-related disorders under medical assessment.
• Individuals with selected liver or blood-related conditions.
• Patients undergoing follow-up when repeat ADA testing is advised.
• People specifically advised to undergo Serum ADA testing by their doctor.

Detailed Information

Adenosine deaminase is an enzyme involved in breaking down adenosine and deoxyadenosine as part of purine metabolism. It is present in many body tissues but is particularly associated with lymphocytes, which are white blood cells involved in immune defence. ADA activity may increase when cell-mediated immunity is strongly stimulated.

Tuberculosis is an infectious disease caused by bacteria belonging to the Mycobacterium tuberculosis complex. The immune response to tuberculosis involves the activation of T lymphocytes and macrophages. This cellular immune activity can be associated with increased ADA levels in certain biological samples.

The diagnostic usefulness of ADA depends significantly on the type of sample tested. ADA measurement in pleural, ascitic, pericardial, or cerebrospinal fluid may be requested when tuberculosis involving those body cavities is suspected. A Serum ADA test measures ADA activity in blood and is different from an ADA test performed on body fluid.

Serum ADA may provide supportive information, but it cannot independently confirm active tuberculosis. Increased serum ADA activity may also occur in liver disease, infectious mononucleosis, sarcoidosis, brucellosis, typhoid fever, rheumatoid conditions, leukaemia, lymphoma, and other infections or inflammatory disorders.

A normal Serum ADA result does not completely rule out tuberculosis. ADA activity can vary with the stage of illness, immune response, treatment status, patient characteristics, and laboratory method. Therefore, doctors do not interpret the result as a simple positive or negative diagnosis.

When tuberculosis is suspected, the doctor may recommend sputum smear microscopy, mycobacterial culture, nucleic-acid amplification testing, chest X-ray, CT imaging, tuberculin skin testing, interferon-gamma release assays, biopsy, or examination of an affected body fluid. The investigations selected depend on symptoms and the suspected site of infection.

Reference intervals and clinical decision limits may differ between laboratories because testing methods and patient populations vary. The result should always be interpreted using the reference range printed on the individual laboratory report.

Repeat testing may occasionally be advised to assess changes over time. However, changes in Serum ADA should not be used alone to determine whether tuberculosis treatment is working. Clinical improvement, microbiological findings, imaging, and other laboratory results remain important.

At Focus Diagnostics, Adenosine Deaminase – Serum testing is performed using established biochemical methods, appropriate sample-processing procedures, and laboratory quality controls to provide reliable results for clinical interpretation.